Search

Showing "11155" results for ""

Near-global nelfinavir (Viracept) recall 'very difficult situation'

Maraviroc approval delayed in the US

TB treatment and HBV: risk factors for liver toxicity in South Africans on antiretroviral therapy

Hospital admissions involving people with HIV fall by 40% between 2000 and 2004 in US

Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

HPV vaccinations recommended in UK for 12 and 13 year-old girls

WHO issues clarification on pharmacovigilance funding

Oral solution of bevirimat provides encouraging results, maturation inhibitor moves ahead

Global MDR and XDR TB control needs extra $2.15 billion by end of 2008, says WHO

Four-year analysis of tenofovir finds “favourable safety profile”

A short course of potent HIV therapy during primary infection may slow longer-term disease progression

Offer second HIV test late in pregnancy to women with high HIV risk

UNAIDS and UK both issue draft confidentiality guidelines for patient record sharing

First-line treatment choices proving challenging for African ART programmes

Opt-out HIV testing not efficient in US, suggests researcher

HIV treatment and displaced populations

Merck hopes for US integrase inhibitor license by October

MSM in Africa: highly stigmatised, vulnerable and in need of urgent HIV prevention

Receive the latest HIV research and conference news

Showing "11155" results for ""

Near-global nelfinavir (Viracept) recall 'very difficult situation'

Maraviroc approval delayed in the US

TB treatment and HBV: risk factors for liver toxicity in South Africans on antiretroviral therapy

Hospital admissions involving people with HIV fall by 40% between 2000 and 2004 in US

Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

HPV vaccinations recommended in UK for 12 and 13 year-old girls

WHO issues clarification on pharmacovigilance funding

Oral solution of bevirimat provides encouraging results, maturation inhibitor moves ahead

Global MDR and XDR TB control needs extra $2.15 billion by end of 2008, says WHO

Four-year analysis of tenofovir finds “favourable safety profile”

A short course of potent HIV therapy during primary infection may slow longer-term disease progression

Offer second HIV test late in pregnancy to women with high HIV risk

UNAIDS and UK both issue draft confidentiality guidelines for patient record sharing

First-line treatment choices proving challenging for African ART programmes

Opt-out HIV testing not efficient in US, suggests researcher

HIV treatment and displaced populations

Merck hopes for US integrase inhibitor license by October

MSM in Africa: highly stigmatised, vulnerable and in need of urgent HIV prevention

Receive the latest HIV research and conference news